Form 4: Eli Lilly Executive Anne E. White Reports Stock Transactions
SEC Form 4 Filing
EVP and President of Lilly Neuroscience, Anne E. White, reports the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.
Summary
- Anne E. White, EVP & President of Lilly Neuroscience, reported transactions involving Eli Lilly & Co [LLY] common stock on February 1, 2025.
- These transactions involved the vesting of 3,269 restricted stock units, each representing a contingent right to receive one share of Eli Lilly and Company common stock.
- Following the vesting, 1,457.102 shares were disposed of at a price of $811.08 per share to cover tax obligations.
- After these transactions, White directly owns 67,380.898 shares of Eli Lilly common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock transactions are a routine part of corporate governance and are closely watched by investors for insights into management's perspective on the company's performance and future prospects. Form 4 filings provide transparency into these transactions.
Key Dates
| Date | Description |
|---|---|
| 02/01/2025 | Date of earliest transaction: vesting of restricted stock units and disposition of shares. |
| 02/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.